The genomic revolution is happening now, and it is changing everything we know about science, medicine, and nature. As the leading genomics research institute in the world, the J. Craig Venter Institute (JCVI) is on the frontline of this revolution, and we are making new and exciting discoveries every day. And we are still in the inception - JCVI researchers have only just begun to unlock the mysteries and true potential of genomics to improve human health and the environment. The future of genomics is limitless.
JCVI was founded in 1992 by J. Craig Venter, Ph.D. and a pioneering, multidisciplinary team of researchers with bold ideas and the passion to turn their visions into reality. In 2000, Dr. Venter successfully sequenced the entire human genome, ushering in the revolution by finally revealing the DNA code that runs our cells and controls life as we know it. This groundbreaking breakthrough transformed science and caused a paradigm shift that continues to foster new discoveries, medical therapies, industrial applications and invaluable scientific progress.
Today, JCVI continues to lead the field with programs in genomic medicine, infectious disease, microbial and environmental genomics, plant genomics, synthetic biology and bioenergy, sequencing, informatics, environment, education and policy. JCVI researchers boast a set of unrivaled accomplishments including: sequencing the first diploid human genome and the first human microbiome, an environmental genomics program, new methods for detecting and combatting infectious disease agents, and construction of the first synthetic cell.
We also recently completed building JCVI La Jolla - the only net-zero energy biological research institute in the world. This ultra-high efficiency building (LEED Platinum pending) is both beautiful and practical, and a perfect home for the cutting edge research taking place within its walls.
JCVI is growing and changing to keep pace with the speed of discovery and progress, but we remain true to Dr. Venter’s unifying vision – JCVI is committed to positively impact and advance human health and the environment through innovative, genomics-based scientific research.